about
A locking mechanism preventing radical damage in the absence of substrate, as revealed by the x-ray structure of lysine 5,6-aminomutasePrevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement EffortsCost-effectiveness of treatment of diabetic macular edema.Optimal surveillance strategies for bovine tuberculosis in a low-prevalence countryIdentifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach.Inferring model parameters in network-based disease simulation.Link removal for the control of stochastically evolving epidemics over networks: a comparison of approachesBehavioral and community correlates of adolescent pregnancy and Chlamydia rates in rural counties in Minnesota.Optimal link removal for epidemic mitigation: a two-way partitioning approachFrom network analysis to risk analysis--An approach to risk-based surveillance for bovine tuberculosis in Minnesota, US.An Overview of R in Health Decision Sciences.Evaluating empirical contact networks as potential transmission pathways for infectious diseases.Using Multiple Outcomes of Sexual Behavior to Provide Insights Into Chlamydia Transmission and the Effectiveness of Prevention Interventions in Adolescents.Network analysis of cattle movements in Uruguay: Quantifying heterogeneity for risk-based disease surveillance and control.Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model.Modeling cost-effectiveness of risk-based bovine tuberculosis surveillance in MinnesotaCost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial ResistanceDecision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant WomenA Need for Change! A Coding Framework for Improving Transparency in Decision ModelingRevisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infectionsNonidentifiability in Model Calibration and Implications for Medical Decision Making"Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and FrontierAge-related decreases in relapses among adults with relapsing-onset multiple sclerosisHIV Care Trajectories as a Novel Longitudinal Assessment of Retention in CareInforming Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple SclerosisProactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
P50
Q24560013-F55DA849-F942-4C56-B437-D4A57C60A410Q28005532-2AC6BB43-3797-4B9A-9F13-4BB334480094Q31128135-83CF0DF3-530C-4B9C-B918-905167E14289Q33606611-7782EAB6-0DDD-47DD-8F85-37DE192E3D63Q33830112-5BEC7CA5-0B07-47C5-B160-759E5C4C416EQ34778132-D6F2A8CC-A176-4E09-9113-F69EA7E51CB9Q35025477-BE1537C8-B2DE-4736-BA65-8A2B81B155D5Q35213941-BD376D58-3D4A-487C-B597-8BB02F9C8B41Q35539148-4B541E62-DB0B-467A-82FB-C312AEDD30F7Q36211643-956ACB5F-A9E2-4196-A7E1-92D97C839A5AQ39061728-A298C2C4-2C79-49BD-B0FB-CE980B39AB88Q39070617-AADF0E16-7AEE-463F-92A8-6DDD3500DC5CQ39528074-5697C9F0-EA65-4F58-BFB4-4A4842074031Q40056113-735F5960-E672-4A32-9B7D-7C794EE81D2DQ40167637-BAA631F8-EE68-4C4F-A12F-60D06DFAEB36Q40891018-15E4640D-0F34-4FCA-B56C-BE54F962F4BAQ44561011-5DBF54AA-8445-4BC7-A964-5CC1E23D4F5DQ51828856-40BFAE8F-3C6A-43CC-906E-3FC27DD447CAQ52340299-6D8487F1-9F03-454E-A931-65404B72F766Q54235657-A648FA52-4099-4CE5-AE5E-1C571E1ED457Q57456291-533B98BE-21C8-4EF5-8F3E-6FCC1F645EF9Q88135178-C081BC0B-4ED7-4B9E-B025-E03CE71B77D9Q89713085-E0C2B063-1785-47F9-9D7B-4BEB716E0D64Q90248177-D2B332F4-C055-421C-8A9F-5AB33F18AD00Q90858179-041C4909-A79A-4908-A0A6-2A052933CDBEQ91689068-9560ABAB-43FF-46F1-9F84-AD73A7C35686Q92142390-BA856644-8389-4FD1-AF89-2521756E969BQ92235532-85D404B9-BB04-427D-A96F-DAD6BFD2F0A5Q92248637-B07E0884-5966-4B55-ACA5-AF925A885972Q92508839-3267B30A-C277-4A91-A6E2-6D2B4A2C4751Q92653248-EE3469FB-63BB-4B10-9E1D-BD5B96172A25
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eva A Enns
@ast
Eva A Enns
@en
Eva A Enns
@es
Eva A Enns
@nl
type
label
Eva A Enns
@ast
Eva A Enns
@en
Eva A Enns
@es
Eva A Enns
@nl
prefLabel
Eva A Enns
@ast
Eva A Enns
@en
Eva A Enns
@es
Eva A Enns
@nl
P101
P1153
36090775900
P31
P496
0000-0003-0693-7358